A Case of Sporadic Creutzfeldt-Jakob Disease with a Long Survival Period of 17 Months (P11-12.007)

Q: What does this research mean for the field?

Sporadic Creutzfeldt-Jakob Disease (sCJD) can present with atypical slow progression and prolonged survival periods, representing a subset of cases that are currently underrepresented in the literature. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

Nhan Ly; Martin Eicke

doi:10.1212/wnl.0000000000216077

June 9, 2026Neurology

A Case of Sporadic Creutzfeldt-Jakob Disease with a Long Survival Period of 17 Months (P11-12.007)

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to describe a unique case of sporadic CJD with a prolonged survival period.
Reviewed a case of sporadic Creutzfeldt-Jakob Disease with 17 months of survival.
Analyzed genetic forms and subtypes related to prolonged progression.
Documented an extended survival period of 17 months in a patient with sporadic CJD.
Identified and highlighted underrepresented sCJD subtypes and genetic forms.

Implication

Case report highlights slow progression in sporadic CJD and underrepresented subtypes in literature.

Abstract

We describe a case of sporadic CJD (sCJD) with slow progression and highlight certain prolonged-progressing sCJD subtypes and genetic forms, which are underrepresented in literature.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ly et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf393faef96ed7f0560cc https://doi.org/10.1212/wnl.0000000000216077

View Full Paper

Ask AI

Bookmark

Share

A Case of Sporadic Creutzfeldt-Jakob Disease with a Long Survival Period of 17 Months (P11-12.007)

Key Points

Implication

Abstract

Discussion

Cite This Study

A Case of Sporadic Creutzfeldt-Jakob Disease with a Long Survival Period of 17 Months (P11-12.007)

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading